Google_______________

Hepatitis C Viremia, but Not Hepatitis B, Is Associated with Increased Risk of Diabetes

There is growing evidence regarding the association between hepatitis C virus (HCV) infection and type 2 diabetes mellitus. However, the impact of hepatitis B virus (HBV) infection on the link between HCV and diabetes remains unclear.

As reported in the June 2007 American Journal of Gastroenterology, researchers conducted a study to elucidate the link between type 2 diabetes and viral hepatitis infections, especially HCV.

The authors performed a cross-sectional analysis of a computer-sampling survey among 10,975 participants (aged 40-65 years) in an area endemic for HBV and HCV infections in Taiwan; out of this group, 9,932 eligible participants were selected for further analysis.

Results

13.1% of participants were seropositive for HBV surface antigen (HBsAg), 6.5% had anti-HCV antibodies, and 4.8% had detectable HCV viremia.

The prevalence of type 2 diabetes was 12.5%

The prevalence of HCV viremia was significantly different in subjects with and without type 2 diabetes (6.9% vs 4.5%, respectively; P < 0.001).

Anti-HCV antibody seropositivity showed borderline significance (7.8% vs 6.3%; P = 0.047).

There was no difference between HCV genotypes 1 and 2 in the association with diabetes.

The prevalence of HBsAg positivity did not differ between subjects with and without diabetes (12.5% vs 13.9%; P= 0.19).

The prevalence of type 2 diabetes among subjects with HCV viremia (18.0%) was significantly higher than that among HBsAg positive subjects (11.4%; P = 0.001) and those negative for both HBV and HCV (12.5%; P= 0.001).

Multivariate logistic regression analyses showed that HCV viremia was the most significant factor associated with type 2 diabetes, followed by male sex, hypertension, body mass index, and age.

Conclusion

"HBV infection did not increase the association with type 2 diabetes mellitus," the authors concluded. "A significant mutual link between type 2 diabetes and HCV viremia existed in this HBV/HCV endemic area. There was no HCV genotype-specific difference between HCV genotype 1 and 2 in the association with type 2 diabetes."

07/17/07

Reference
JF Huang, CY Dai, SJ Hwang, and others. Hepatitis C viremia increases the association with type 2 diabetes mellitus in a hepatitis B and C endemic area: an epidemiological link with virological implication. American Journal of Gastroenterology 102(6): 1237-1243. June 2007.


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

FDA-approved
Monotherapies for HCV
Intron A
Roferon

Infergen

Pegasys

PEG-Intron

FDA-approved
Combination
Therapies
for HCV
Pegasys + Copegus
PEG-Intron + Rebetol
Intron A + Rebetol
Roferon A + Ribavirin
Index of All
Hepatitis C Articles
by Topic ( A to Z)